Cargando…
The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study
BACKGROUND: Aldehyde dehydrogenase 1 (ALDH1) is widely used as a specific cancer stem cell marker in a variety of cancers, and may become a promising target for cancer therapy. However, the role of its expression in tumor cells and the microenvironment in different cancers is still controversial. ME...
Autores principales: | Huang, Ruixia, Li, Xiaoran, Holm, Ruth, Trope, Claes G., Nesland, Jahn M., Suo, Zhenhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494797/ https://www.ncbi.nlm.nih.gov/pubmed/26148881 http://dx.doi.org/10.1186/s12885-015-1513-5 |
Ejemplares similares
-
Sex Hormone-Binding Globulin (SHBG) Expression in Ovarian Carcinomas and Its Clinicopathological Associations
por: Huang, Ruixia, et al.
Publicado: (2013) -
Expression of zinc finger E-box-binding homeobox factor 1 in epithelial ovarian cancer: A clinicopathological analysis of 238 patients
por: LI, XIUFANG, et al.
Publicado: (2016) -
CD117 Expression in Fibroblasts-Like Stromal Cells Indicates Unfavorable Clinical Outcomes in Ovarian Carcinoma Patients
por: Huang, Ruixia, et al.
Publicado: (2014) -
The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas
por: Wang, Zhihui, et al.
Publicado: (2008) -
The Prognostic Value of 14-3-3 Isoforms in Vulvar Squamous Cell Carcinoma Cases: 14-3-3β and ε Are Independent Prognostic Factors for These Tumors
por: Wang, Zhihui, et al.
Publicado: (2011)